Search

everythinglearnresearchcommunity

for

Search:↓

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Balding and low testosterone increase risk of urinary stones.

Metformin is less effective in men with early-onset hair loss.

Evening primrose oil significantly improves hormone levels and reduces BMI and cholesterol in women with PCOS.

Metformin lowers gremlin-1 and improves insulin resistance in women with PCOS.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Eating disorders can cause various hair problems, and while hair loss in these disorders is linked to metabolic syndrome, treatment focuses on specific medications and lifestyle changes for the syndrome.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Women with Polycystic Ovary Syndrome have higher levels of the hormone ghrelin, which may be linked to the cause of the condition.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

The Random Forest algorithm was the most accurate at diagnosing Polycystic Ovarian Syndrome.

Myo-inositol and D-chiro-inositol improve hormonal and physical symptoms in teenage girls with PCOS.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Men with early hair loss and hormonal changes like PCOS could be the male equivalent of PCOS, not linked to metabolic syndrome.

People with androgenetic alopecia have a higher risk of metabolic syndrome.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Premature hair loss doesn't increase the risk of metabolic syndrome.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Obese women with PCOS are more likely to have fatty liver disease.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

Women with PCOS need more support to cope with isolation, helplessness, and grief, and to build resilience.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.